In addition, the risk of developing thyroid cancer is increased in patients with autoimmune thyroid disease and thyroid dysfunction is one of the most common irAEs, especially with PD‐1/PD-L1 blockade. Here, PDCD1 is linked to autoimmune thyroid disease.